IP Library Granted Patent US 10,544,384
Granted Patent B2
US 10,544,384 · App. 15/546,297 · Granted Jan 28, 2020

Skin cleansing composition containing rhamnolipid and siloxane

Inventors: Ralph Scheuermann (Bottrop, DE); Marcel Pickl (Bottrop, DE); Michael Ferenz (Essen, DE); Hans Henning Wenk (Mülheim an der Ruhr, DE); Martin Schilling (Bonn, DE); Kathrin Daniela Brandt (Düsseldorf, DE); Verena Dahl (Kürten, DE)
Assignee: Evonik Degussa GmbH
C11D3/3738A61K8/602A61K8/894A61Q19/10C11D1/06C11D1/83A61K2800/86C11D1/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,544,384
App. No.
15/546,297
Granted
Jan 28, 2020
Kind
B2
Abstract

The invention provides compositions comprising at least one rhamnolipid and at least one siloxane, characterized in that the weight ratio of rhamnolipid to siloxane is from 5,000,000:1 to 100:1, preferably from 500,000:1 to 1000:1, particularly preferably from 25,000:1 to 2500:1. In another embodiment, the invention provides compositions include rhamnolipid in an amount of from 0.5% by weight to 70% by weight, preferably from 2% by weight to 60% by weight, particularly preferably from 3% by weight to 50% by weight, where the percentages by weight refer to the total composition.

Claims (69)

1. An aqueous skin cleansing composition comprising a rhamnolipid and a siloxane,

wherein the rhamnolipid comprises a rhamnolipid salt comprising rhamnolipid anions and cations selected from the group consisting of Li + , Na + , K + , Mg 2+ , Ca 2+ , Al 3+ , NH 4 + , and triethanolammonium,

wherein the weight ratio of the rhamnolipid to the siloxane is from 25,000:1 to 2,500:1,

wherein the weight ratio of the rhamnolipid to the siloxane is the sum of all the rhamnolipid contained in the composition to the siloxane of all siloxanes contained in the composition,

wherein the composition comprises a mixture of rhamnolipid,

wherein the weight ratio of di-rhamnolipids to mono-rhamnolipids in the mixture is greater than 98:2,

wherein the composition comprises rhamnolipid in an amount of from 12% by weight to 70% by weight, wherein the percentages by weight refer to the total composition and take all rhamnolipid present in the composition, and

wherein the rhamnolipid mixture comprises

from 51% by weight to 95% by weight of diRL-C10C10, and

from 0.5% by weight to 9% by weight of monoRL-C10C10,

where the percentages by weight refer to the sum total of all rhamnolipids present.

2. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises the rhamnolipid in an amount of from 15% by weight to 60% by weight, wherein the percentages by weight refer to the total composition, and

wherein the rhamnolipid mixture comprises

from 70% by weight to 90% by weight of diRL-C10C10,

from 0.5% by weight to 3% by weight of monoRL-C10C10, and

from 0.5% by weight to 15% by weight of diRL-C10C12:1,

where the percentages by weight refer to the sum total of all rhamnolipids present.

3. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises the rhamnolipid in an amount of from 25% by weight to 50% by weight wherein the percentages by weight refer to the total composition.

4. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises a mixture of rhamnolipid, where the weight ratio of di-rhamnolipids to mono-rhamnolipids in the mixture is greater than 51:49.

5. The aqueous skin cleansing composition according to claim 1 , wherein the composition is an aqueous composition and has a pH of from 5.5 to 6.9.

6. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises of rhamnolipid anions in an amount of from 70% by weight to 95% by weight wherein the percentages by weight refer to the total composition.

7. The aqueous skin cleansing composition according to claim 1 , wherein the siloxane is selected from the group consisting of silicone oils, silicone waxes, silicon-functional siloxanes, organofunctional siloxanes, polydiethylsiloxanes, siloxanes having functional groups and organomodified siloxanes.

8. The aqueous skin cleansing composition according to claim 1 , wherein the siloxane is present in an amount of from 0.1 ppm to 5000 ppm by weight of the composition.

9. A formulation comprising the aqueous skin cleansing composition according to claim 1 .

10. The formulation according to claim 9 , wherein the formulation comprises at least one further surfactant.

11. A cleaning surface comprising the aqueous skin cleansing composition according to claim 1 .

12. The aqueous skin cleansing composition according to claim 1 , wherein the rhamnolipid mixture comprises

from 75% by weight to 85% by weight of diRL-C10C10,

from 0.5% by weight to 2% by weight of monoRL-C10C10,

from 0.5% by weight to 15% by weight of diRL-C10C12:1,

where the percentages by weight refer to the sum total of all rhamnolipids present.

13. The aqueous skin cleansing composition according to claim 1 , wherein the rhamnolipid mixture comprises

from 0.5% by weight to 3% by weight of monoRL-C10C12, and

from 0.1% by weight to 5% by weight of monoRL-C10C12:1,

where the percentages by weight refer to the sum total of all rhamnolipids present.

14. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises the rhamnolipid in an amount of from 2% by weight to 60% by weight, where the percentages by weight refer to the total composition.

15. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises the rhamnolipid in an amount of from 20% by weight to 50% by weight, where the percentages by weight refer to the total composition.

16. The composition according to claim 1 , wherein the rhamnolipid mixture comprises

from 0.5% by weight to 2% by weight of monoRL-C10C12, and

from 0.5% by weight to 3% by weight of monoRL-C10C12:1,

where the percentages by weight refer to the sum total of all rhamnolipids present.

17. The aqueous skin cleansing composition according to claim 1 , wherein the composition is an aqueous composition and has a pH of from 5.6 to 6.0.

18. The aqueous skin cleansing composition according to claim 1 , wherein the composition comprises rhamnolipid cations in an amount of from 80% by weight to 90% by weight of all cations present in the composition except H + and H 3 O + .

19. The aqueous skin cleansing composition according to claim 1 , wherein the siloxane is selected from polyethersiloxanes of formula II:

M a M 1 b D c D 1 d T e Q f   Formula II

wherein

a =2-10,

b =0-10,

c =3-500,

d =1.5-15,

e =0-10,

f =0-10,

wherein, a+b≥2 and N=a+b+c+d+e+f≤2050, and b+d≥1

R S2 is selected from the group consisting of alkyl radicals having 1-16 carbon atoms, aryl radicals having 6-16 carbon atoms, H, and OR S4 ,

R S4 is selected from the group consisting of alkyl radicals having 1-16 carbon atoms, aryl radicals having 6-16 carbon atoms, and H,

R S3 is selected from the group consisting of polyether radicals, of the general formula III

wherein

R S5 is selected from the group consisting of alkyl radicals having 1 to 18 carbon atoms which have ether functions, or aryl radicals having 6-18 carbon atoms,

R S6 is selected from the group consisting of R S8 , H, —C(O)R S8 ,

R S7 is selected from the group consisting of divalent organic radicals,

R S8 is selected from the group consisting of alkyl radicals having 1-16 carbon atoms and aryl radicals having 6-16 carbon atoms,

wherein

h=0 or 1,

i=0-50,

j=0-50,

k=0-50,

l=0-40,

wherein i+j+k+1≥3.

20. The aqueous skin cleansing composition according to claim 1 , wherein the siloxane is present in an amount of from 1 ppm to 500 ppm by weight of the composition.

Assignments (2)
CHANGE OF NAME Recorded Dec 27, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051428/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: SCHEUERMANN, RALPH; PICKL, MARCEL; FERENZ, MICHAEL; HENNING WENK, HANS; SCHILLING, MARTIN; BRANDT, KATHRIN DANIELA; DAHL, VERENA
To: EVONIK DEGUSSA GMBH
Reel/Frame 043338/0485 →
Priority Claims (1)
EP 15156961 · Feb 27, 2015 · regional
Continuity (1)
Related Publication 20180016525A1 · Jan 18, 2018
Cited By (2)
US 12,448,588 US 12,497,426